Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Editas Medicine Inc.

    NASDAQ: EDIT · Real-Time Price · USD
    2.15
    0.18 (9.14%)
    At close: Jun 16, 2025, 3:59 PM
    2.16
    0.23%
    Pre-market: Jun 17, 2025, 04:54 AM EDT

    Editas Medicine Statistics

    Share Statistics

    Editas Medicine has 83.71M shares outstanding. The number of shares has increased by 0.9% in one year.

    Shares Outstanding

    n/a
    		 83.71M

    Shares Change (YoY)

    n/a
    		 0.9%

    Shares Change (QoQ)

    n/a
    		 0.52%

    Owned by Institutions (%)

    n/a
    		 61.89%

    Shares Floating

    n/a
    		 82.95M

    Failed to Deliver (FTD) Shares

    n/a
    		 432

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    The latest short interest is 9M, so 10.75% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 9M

    Short % of Shares Out

    n/a
    		 10.75%

    Short % of Float

    n/a
    		 10.78%

    Short Ratio (days to cover)

    n/a
    		 5.31

    Valuation Ratios

    The PE ratio is -0.44 and the forward PE ratio is -1.74. Editas Medicine's PEG ratio is -0.01.

    PE Ratio

    n/a
    		 -0.44

    Forward PE

    n/a
    		 -1.74

    PS Ratio

    n/a
    		 3.24

    Forward PS

    n/a
    		 16.6

    PB Ratio

    n/a
    		 0.78

    P/FCF Ratio

    n/a
    		 -0.48

    PEG Ratio

    n/a
    		 -0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Editas Medicine.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.75, with a Debt / Equity ratio of 0.26.

    Current Ratio

    n/a
    		 3.75

    Quick Ratio

    n/a
    		 3.75

    Debt / Equity

    n/a
    		 0.26

    Debt / EBITDA

    n/a
    		 -0.15

    Debt / FCF

    n/a
    		 -0.16

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $131,357.72

    Profits Per Employee

    n/a
    		 $-963,792.68

    Employee Count

    n/a
    		 246

    Asset Turnover

    n/a
    		 0.09

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -57.59% in the last 52 weeks. The beta is 2.1, so Editas Medicine's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.1

    52-Week Price Change

    n/a
    		 -57.59%

    50-Day Moving Average

    n/a
    		 1.56

    200-Day Moving Average

    n/a
    		 2.09

    Relative Strength Index (RSI)

    n/a
    		 64.12

    Average Volume (20 Days)

    n/a
    		 1,974,825

    Income Statement

    In the last 12 months, Editas Medicine had revenue of 32.31M and earned -237.09M in profits. Earnings per share was -2.88.

    Revenue

    n/a
    		 32.31M

    Gross Profit

    n/a
    		 26.5M

    Operating Income

    n/a
    		 -238.92M

    Net Income

    n/a
    		 -237.09M

    EBITDA

    n/a
    		 -231.28M

    EBIT

    n/a
    		 -238.92M

    Earnings Per Share (EPS)

    n/a
    		 -2.88
    Full Income Statement

    Balance Sheet

    The company has 131.54M in cash and 35.03M in debt, giving a net cash position of 96.51M.

    Cash & Cash Equivalents

    n/a
    		 131.54M

    Total Debt

    n/a
    		 35.03M

    Net Cash

    n/a
    		 96.51M

    Retained Earnings

    n/a
    		 -1.47B

    Total Assets

    n/a
    		 263.65M

    Working Capital

    n/a
    		 151.73M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -210.28M and capital expenditures -8.83M, giving a free cash flow of -219.11M.

    Operating Cash Flow

    n/a
    		 -210.28M

    Capital Expenditures

    n/a
    		 -8.83M

    Free Cash Flow

    n/a
    		 -219.11M

    FCF Per Share

    n/a
    		 -2.66
    Full Cash Flow Statement

    Margins

    Gross margin is 82.02%, with operating and profit margins of -739.37% and -733.72%.

    Gross Margin

    n/a
    		 82.02%

    Operating Margin

    n/a
    		 -739.37%

    Pretax Margin

    n/a
    		 -733.72%

    Profit Margin

    n/a
    		 -733.72%

    EBITDA Margin

    n/a
    		 -715.74%

    EBIT Margin

    n/a
    		 -739.37%

    FCF Margin

    n/a
    		 -678.07%

    Dividends & Yields

    EDIT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for EDIT is $4, which is 86% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $4

    Price Target Difference

    n/a
    		 86%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 13
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -9.17

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist